The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...

Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of multiple malignant tumors. To date, toripalimab has been approved for marketing ...

Greece on Monday prosecuted a pair of protected witnesses in a long-running bribery probe involving Swiss pharmaceutical firm Novartis for alleged perjury, a justice source said.

The government will announce this afternoon whether it will agree to a halt on specific new EU laws requested under the ...

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...

Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...

The past few years have been a roller coaster ride for M&A in pharma and biotech. After the highs of the pandemic came ...

© 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.